Related Experiment Videos

Corticosteroids may improve clinical outcomes during hospitalization for Henoch-Schönlein purpura

Pamela F Weiss1, Andrew J Klink, Russell Localio

  • 1Division of Rheumatology, Children's Hospital of Philadelphia, and Department of Pediatrics, Center for Clinical Epidemiology and Biostatistics, Leonard Davis Institute of Health Economics, University of Pennsylvania School of Medicine, Room 1539, North Campus, 3535 Market St, Philadelphia, PA 19104, USA. weisspa@email.chop.edu

Pediatrics
|September 22, 2010
PubMed

Insights

Early corticosteroid use in hospitalized children with Henoch-Schönlein purpura (HSP) was linked to fewer gastrointestinal complications. This included reduced need for abdominal surgery, endoscopy, and imaging during their hospital stay.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Pediatrics
  • Pharmacological Outcomes

Background:

  • Henoch-Schönlein purpura (HSP) is a common vasculitis in children, often presenting with gastrointestinal (GI) manifestations.
  • The role of corticosteroids in managing acute HSP during hospitalization remains a subject of clinical interest.
  • Understanding treatment effects on specific clinical outcomes is crucial for optimizing pediatric care.

Purpose of the Study:

  • To evaluate the impact of corticosteroid exposure on clinical outcomes in children hospitalized with new-onset HSP.
  • To analyze the association between early corticosteroid treatment and the risk of specific adverse events during hospitalization.

Main Methods:

  • Retrospective cohort study utilizing inpatient administrative data from 36 tertiary children's hospitals (2000-2007).
  • Included children discharged with an HSP diagnosis code.
  • Stratified Cox proportional hazards regression models assessed time-varying corticosteroid exposure effects on hospitalization outcomes.

Main Results:

  • A total of 1895 hospitalizations for new-onset HSP were analyzed.
  • Early corticosteroid exposure significantly reduced the hazard ratios for abdominal surgery (0.39), endoscopy (0.27), and abdominal imaging (0.50).
  • These findings were adjusted for multivariable regression modeling.

Conclusions:

  • Early corticosteroid administration in the hospital setting demonstrated benefits for key clinical outcomes in pediatric HSP.
  • The observed benefits were particularly noted for outcomes related to the gastrointestinal manifestations of HSP.
  • Corticosteroids may play a role in mitigating severe GI complications during acute HSP hospitalizations.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...